Predictive Oncology Inc.’s (NASDAQ: POAI) Unique Assets, AI Capability Address Unmet Need in Growing Field of Precision Medicine
Predictive Oncology is at forefront of growing trend of precision medicine The company applies smart tumor profiling, AI platform to extensive genomic and biomarker patient data sets POAI has large amounts of historical, standardized patient data from clinical testing that can be leveraged immediately The moment has come for Predictive Oncology Inc. (NASDAQ: POAI). A knowledge-driven, precision-medicine company, POAI focuses on applying data and artificial intelligence to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to predict clinical outcomes and, most importantly, improve clinical outcomes…